Your browser doesn't support javascript.
loading
Effects of losartan combined with Bailing capsule on oxidative stress, renal function and microinflammation in patients with chronic kidney disease / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy ; (12): 326-329, 2021.
Article in Chinese | WPRIM | ID: wpr-883762
ABSTRACT

Objective:

To investigate the effects of losartan combined with Bailing capsule on oxidative stress, renal function and microinflammation in patients with chronic kidney disease.

Methods:

Ninety-four patients with chronic kidney disease who received treatment in Rong Jun Hospital from September 2018 to September 2019 were included in this study. They were randomly assigned to receive treatment with either oral losartan (control group, n = 47) or oral losartan combined with Bailing capsule (treatment group, n = 47) for 24 weeks. Preoperative and postoperative oxidative stress, renal function and microinflammatory factor level as well as clinical efficacy were compared between the control and treatment groups.

Results:

Total effective rate in the treatment group was significantly higher than that in the control group [91.49% (43/47) vs. 68.09% (32/47), χ 2 = 7.982, P < 0.05]. After treatment, superoxide dismutase and glutathione peroxidase levels in the treatment group were significantly higher than those in the control group [superoxide dismutase (138.16 ± 5.67) U/L vs. (119.74 ± 3.64) U/L, glutathione peroxidase (48.20 ± 3.78) U/L vs. (41.36 ± 3.29) U/L, t =18.742, 9.358, both P < 0.05]. After treatment, malondialdehyde level in the observation group was significantly lower than that in the control group [(2.78 ± 0.32) mmol/L vs. (3.21 ± 0.38) mmol/L, t = 5.934, P < 0.05]. After treatment, serum urea nitrogen [(4.32 ± 0.45) mmol/L] and creatinine [(54.45 ± 8.98) mmol/L] in the treatment group were significantly lower than those in the control group [(6.53 ± 0.62) mmol/L and (78.31 ± 10.16) mmol/L, t = 19.777, 12.063, both P < 0.05]. After treatment, serum levels of tumor necrosis factor-α [(58.36 ± 6.64) μg/L], hypersensitive C-reactive protein [(3.94 ± 1.25) mg/L] and interleukin-18 [(176.58 ± 17.49) ng/L] in the treatment group were significantly lower than those in the control group [(71.32 ± 6.07) μg/L, (6.87 ± 1.49) mg/L and (229.31 ± 20.09) ng/L, t = 9.876, 10.328, 13.572, all P < 0.05].

Conclusion:

Losartan combined with Bailing capsule can improve oxidative stress, renal function and microinflammation in patients with chronic kidney disease and can achieve good clinical efficacy.
Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Primary Medicine and Pharmacy Year: 2021 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Language: Chinese Journal: Chinese Journal of Primary Medicine and Pharmacy Year: 2021 Type: Article